Covid-19 Impact on Natural Killer (NK) Cell Therapeutics Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Natural Killer (NK) Cell Therapeutics, including the following market information:
Major competitors identified in this market include Chipscreen Biosciences (China), Affimed NV (Netherlands), Altor BioScience Corporation (USA), Innate Pharma SA (France), Takeda Pharmaceutical (Japan), Sorrento Therapeutics Inc. (USA), NantKwest Inc. (USA), Bristol-Myers Squibb (USA), NKT Therapeutics (USA), etc.
Based on the Region:
- Global Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Natural Killer (NK) Cell Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Natural Killer (NK) Cell Therapeutics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Natural Killer (NK) Cell Therapeutics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Chipscreen Biosciences (China), Affimed NV (Netherlands), Altor BioScience Corporation (USA), Innate Pharma SA (France), Takeda Pharmaceutical (Japan), Sorrento Therapeutics Inc. (USA), NantKwest Inc. (USA), Bristol-Myers Squibb (USA), NKT Therapeutics (USA), etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Mogamulizumab
- Lorvotuzumab Mertansine
- Others
- Cancer
- Cardiovascular Diseases
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Natural Killer (NK) Cell Therapeutics Industry
1.7 COVID-19 Impact: Natural Killer (NK) Cell Therapeutics Market Trends
2 GLOBAL NATURAL KILLER (NK) CELL THERAPEUTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Natural Killer (NK) Cell Therapeutics Business Impact Assessment - COVID-19
2.1.1 Global Natural Killer (NK) Cell Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Natural Killer (NK) Cell Therapeutics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Natural Killer (NK) Cell Therapeutics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Natural Killer (NK) Cell Therapeutics Headquarters and Area Served
3.3 Date of Key Players Enter into Natural Killer (NK) Cell Therapeutics Market
3.4 Key Players Natural Killer (NK) Cell Therapeutics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON NATURAL KILLER (NK) CELL THERAPEUTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Mogamulizumab
1.4.2 Lorvotuzumab Mertansine
1.4.3 Others
4.2 By Type, Global Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON NATURAL KILLER (NK) CELL THERAPEUTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Cancer
5.5.2 Cardiovascular Diseases
5.5.3 Others
5.2 By Application, Global Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021
5.2.1 By Application, Global Natural Killer (NK) Cell Therapeutics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Chipscreen Biosciences (China)
7.1.1 Chipscreen Biosciences (China) Business Overview
7.1.2 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product Introduction
7.1.4 Chipscreen Biosciences (China) Response to COVID-19 and Related Developments
7.2 Affimed NV (Netherlands)
7.2.1 Affimed NV (Netherlands) Business Overview
7.2.2 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.2.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product Introduction
7.2.4 Affimed NV (Netherlands) Response to COVID-19 and Related Developments
7.3 Altor BioScience Corporation (USA)
7.3.1 Altor BioScience Corporation (USA) Business Overview
7.3.2 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product Introduction
7.3.4 Altor BioScience Corporation (USA) Response to COVID-19 and Related Developments
7.4 Innate Pharma SA (France)
7.4.1 Innate Pharma SA (France) Business Overview
7.4.2 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.4.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Product Introduction
7.4.4 Innate Pharma SA (France) Response to COVID-19 and Related Developments
7.5 Takeda Pharmaceutical (Japan)
7.5.1 Takeda Pharmaceutical (Japan) Business Overview
7.5.2 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.5.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Product Introduction
7.5.4 Takeda Pharmaceutical (Japan) Response to COVID-19 and Related Developments
7.6 Sorrento Therapeutics Inc. (USA)
7.6.1 Sorrento Therapeutics Inc. (USA) Business Overview
7.6.2 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.6.3 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Product Introduction
7.6.4 Sorrento Therapeutics Inc. (USA) Response to COVID-19 and Related Developments
7.7 NantKwest Inc. (USA)
7.7.1 NantKwest Inc. (USA) Business Overview
7.7.2 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.7.3 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Product Introduction
7.7.4 NantKwest Inc. (USA) Response to COVID-19 and Related Developments
7.8 Bristol-Myers Squibb (USA)
7.8.1 Bristol-Myers Squibb (USA) Business Overview
7.8.2 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Product Introduction
7.8.4 Bristol-Myers Squibb (USA) Response to COVID-19 and Related Developments
7.9 NKT Therapeutics (USA)
7.9.1 NKT Therapeutics (USA) Business Overview
7.9.2 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Product Introduction
7.9.4 NKT Therapeutics (USA) Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Natural Killer (NK) Cell Therapeutics Industry
1.7 COVID-19 Impact: Natural Killer (NK) Cell Therapeutics Market Trends
2 GLOBAL NATURAL KILLER (NK) CELL THERAPEUTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Natural Killer (NK) Cell Therapeutics Business Impact Assessment - COVID-19
2.1.1 Global Natural Killer (NK) Cell Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Natural Killer (NK) Cell Therapeutics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Natural Killer (NK) Cell Therapeutics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Natural Killer (NK) Cell Therapeutics Headquarters and Area Served
3.3 Date of Key Players Enter into Natural Killer (NK) Cell Therapeutics Market
3.4 Key Players Natural Killer (NK) Cell Therapeutics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON NATURAL KILLER (NK) CELL THERAPEUTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Mogamulizumab
1.4.2 Lorvotuzumab Mertansine
1.4.3 Others
4.2 By Type, Global Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON NATURAL KILLER (NK) CELL THERAPEUTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Cancer
5.5.2 Cardiovascular Diseases
5.5.3 Others
5.2 By Application, Global Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021
5.2.1 By Application, Global Natural Killer (NK) Cell Therapeutics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Chipscreen Biosciences (China)
7.1.1 Chipscreen Biosciences (China) Business Overview
7.1.2 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product Introduction
7.1.4 Chipscreen Biosciences (China) Response to COVID-19 and Related Developments
7.2 Affimed NV (Netherlands)
7.2.1 Affimed NV (Netherlands) Business Overview
7.2.2 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.2.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product Introduction
7.2.4 Affimed NV (Netherlands) Response to COVID-19 and Related Developments
7.3 Altor BioScience Corporation (USA)
7.3.1 Altor BioScience Corporation (USA) Business Overview
7.3.2 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product Introduction
7.3.4 Altor BioScience Corporation (USA) Response to COVID-19 and Related Developments
7.4 Innate Pharma SA (France)
7.4.1 Innate Pharma SA (France) Business Overview
7.4.2 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.4.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Product Introduction
7.4.4 Innate Pharma SA (France) Response to COVID-19 and Related Developments
7.5 Takeda Pharmaceutical (Japan)
7.5.1 Takeda Pharmaceutical (Japan) Business Overview
7.5.2 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.5.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Product Introduction
7.5.4 Takeda Pharmaceutical (Japan) Response to COVID-19 and Related Developments
7.6 Sorrento Therapeutics Inc. (USA)
7.6.1 Sorrento Therapeutics Inc. (USA) Business Overview
7.6.2 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.6.3 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Product Introduction
7.6.4 Sorrento Therapeutics Inc. (USA) Response to COVID-19 and Related Developments
7.7 NantKwest Inc. (USA)
7.7.1 NantKwest Inc. (USA) Business Overview
7.7.2 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.7.3 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Product Introduction
7.7.4 NantKwest Inc. (USA) Response to COVID-19 and Related Developments
7.8 Bristol-Myers Squibb (USA)
7.8.1 Bristol-Myers Squibb (USA) Business Overview
7.8.2 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Product Introduction
7.8.4 Bristol-Myers Squibb (USA) Response to COVID-19 and Related Developments
7.9 NKT Therapeutics (USA)
7.9.1 NKT Therapeutics (USA) Business Overview
7.9.2 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2020
7.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Product Introduction
7.9.4 NKT Therapeutics (USA) Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Natural Killer (NK) Cell Therapeutics Assessment
Table 9. COVID-19 Impact: Natural Killer (NK) Cell Therapeutics Market Trends
Table 10. COVID-19 Impact Global Natural Killer (NK) Cell Therapeutics Market Size
Table 11. Global Natural Killer (NK) Cell Therapeutics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Natural Killer (NK) Cell Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Natural Killer (NK) Cell Therapeutics Market Growth Drivers
Table 14. Global Natural Killer (NK) Cell Therapeutics Market Restraints
Table 15. Global Natural Killer (NK) Cell Therapeutics Market Opportunities
Table 16. Global Natural Killer (NK) Cell Therapeutics Market Challenges
Table 17. By Players, Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Natural Killer (NK) Cell Therapeutics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Natural Killer (NK) Cell Therapeutics Market
Table 21. Key Players Natural Killer (NK) Cell Therapeutics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Natural Killer (NK) Cell Therapeutics Market Size 2019-2021, (US$ Million)
Table 24. Global Natural Killer (NK) Cell Therapeutics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Natural Killer (NK) Cell Therapeutics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 57. Chipscreen Biosciences (China) Business Overview
Table 58. Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product
Table 60. Chipscreen Biosciences (China) Response to COVID-19 and Related Developments
Table 61. Affimed NV (Netherlands) Business Overview
Table 62. Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product
Table 64. Affimed NV (Netherlands) Response to COVID-19 and Related Developments
Table 65. Altor BioScience Corporation (USA) Business Overview
Table 66. Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product
Table 68. Altor BioScience Corporation (USA) Response to COVID-19 and Related Developments
Table 69. Innate Pharma SA (France) Business Overview
Table 70. Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Product
Table 72. Innate Pharma SA (France) Response to COVID-19 and Related Developments
Table 73. Takeda Pharmaceutical (Japan) Business Overview
Table 74. Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Product
Table 76. Takeda Pharmaceutical (Japan) Response to COVID-19 and Related Developments
Table 77. Sorrento Therapeutics Inc. (USA) Business Overview
Table 78. Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Product
Table 80. Sorrento Therapeutics Inc. (USA) Response to COVID-19 and Related Developments
Table 81. NantKwest Inc. (USA) Business Overview
Table 82. NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Product
Table 84. NantKwest Inc. (USA) Response to COVID-19 and Related Developments
Table 85. Bristol-Myers Squibb (USA) Business Overview
Table 86. Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Product
Table 88. Bristol-Myers Squibb (USA) Response to COVID-19 and Related Developments
Table 89. NKT Therapeutics (USA) Business Overview
Table 90. NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Product
Table 92. NKT Therapeutics (USA) Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Natural Killer (NK) Cell Therapeutics Assessment
Table 9. COVID-19 Impact: Natural Killer (NK) Cell Therapeutics Market Trends
Table 10. COVID-19 Impact Global Natural Killer (NK) Cell Therapeutics Market Size
Table 11. Global Natural Killer (NK) Cell Therapeutics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Natural Killer (NK) Cell Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Natural Killer (NK) Cell Therapeutics Market Growth Drivers
Table 14. Global Natural Killer (NK) Cell Therapeutics Market Restraints
Table 15. Global Natural Killer (NK) Cell Therapeutics Market Opportunities
Table 16. Global Natural Killer (NK) Cell Therapeutics Market Challenges
Table 17. By Players, Natural Killer (NK) Cell Therapeutics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Natural Killer (NK) Cell Therapeutics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Natural Killer (NK) Cell Therapeutics Market
Table 21. Key Players Natural Killer (NK) Cell Therapeutics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Natural Killer (NK) Cell Therapeutics Market Size 2019-2021, (US$ Million)
Table 24. Global Natural Killer (NK) Cell Therapeutics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Natural Killer (NK) Cell Therapeutics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size, 2019-2021 (US$ Million)
Table 57. Chipscreen Biosciences (China) Business Overview
Table 58. Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product
Table 60. Chipscreen Biosciences (China) Response to COVID-19 and Related Developments
Table 61. Affimed NV (Netherlands) Business Overview
Table 62. Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product
Table 64. Affimed NV (Netherlands) Response to COVID-19 and Related Developments
Table 65. Altor BioScience Corporation (USA) Business Overview
Table 66. Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product
Table 68. Altor BioScience Corporation (USA) Response to COVID-19 and Related Developments
Table 69. Innate Pharma SA (France) Business Overview
Table 70. Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Product
Table 72. Innate Pharma SA (France) Response to COVID-19 and Related Developments
Table 73. Takeda Pharmaceutical (Japan) Business Overview
Table 74. Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Product
Table 76. Takeda Pharmaceutical (Japan) Response to COVID-19 and Related Developments
Table 77. Sorrento Therapeutics Inc. (USA) Business Overview
Table 78. Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Product
Table 80. Sorrento Therapeutics Inc. (USA) Response to COVID-19 and Related Developments
Table 81. NantKwest Inc. (USA) Business Overview
Table 82. NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Product
Table 84. NantKwest Inc. (USA) Response to COVID-19 and Related Developments
Table 85. Bristol-Myers Squibb (USA) Business Overview
Table 86. Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Product
Table 88. Bristol-Myers Squibb (USA) Response to COVID-19 and Related Developments
Table 89. NKT Therapeutics (USA) Business Overview
Table 90. NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Product
Table 92. NKT Therapeutics (USA) Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Natural Killer (NK) Cell Therapeutics Product Picture
Figure 2. Natural Killer (NK) Cell Therapeutics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Natural Killer (NK) Cell Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Natural Killer (NK) Cell Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Natural Killer (NK) Cell Therapeutics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Natural Killer (NK) Cell Therapeutics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Natural Killer (NK) Cell Therapeutics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size Market Share, 2019-2021
Figure 1. Natural Killer (NK) Cell Therapeutics Product Picture
Figure 2. Natural Killer (NK) Cell Therapeutics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Natural Killer (NK) Cell Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Natural Killer (NK) Cell Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Natural Killer (NK) Cell Therapeutics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Natural Killer (NK) Cell Therapeutics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Natural Killer (NK) Cell Therapeutics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size Market Share, 2019-2021
